A neurologist who treats and studies Parkinson's has a personal connection to the disease: Her father-in-law, who played in ...

A CHI Health neurologist who treats and studies Parkinson's has a personal connection to the disease: Her father-in-law, who ...

Parkinson's disease a common but complex neurodegenerative disorder that affects 10 million people worldwide. Here are some ...

GOLDEN, Colo. — For 12 years, Paul Stroud’s done everything he can to combat the effects of Parkinson’s disease. He had a ...

On Tuesday, former Packers football player, Brett Favre announced he suffers from Parkinson’s Disease. Parkinson’s Disease is ...

A new study has shown that unilateral deep brain stimulation (DBS) on the right side of the brain improves motor symptoms in ...

More than 20 years later, Alberts and a team of researchers have received a $3 million, five-year award from the National ...

Researchers conducted a retrospective cohort study to compare the effects of SGLT-2 inhibitors and DPP-4 inhibitors on Parkinson disease risk among adults with T2D.

Bayer subsidiary BlueRock Therapeutics has reported encouraging 24-month outcomes from the Phase I exPDite clinical study of ...

The following is a summary of “SGLT2 Inhibitor Use and Risk of Dementia and Parkinson’s Disease Among Patients With Type 2 ...

Parkinson's disease is a neurogenerative disorder that affects predominately the dopamine-producing (dopaminergic) neurons in the brain. People suffering from it face problems in motor movement, ...

Penn Medicine researchers will advance their understanding of the underlying causes of cognitive decline in individuals with Lewy body diseases, like Parkinson's, and identify biomarkers that predict ...